Skip to content

Pharmacy

Camber launches generic Ranexa

Camber launches generic Ranexa

Camber Pharmaceuticals has added ranolazine ER tablets to its current portfolio. Ranolazine ER tablets is a prescription medicine used to treat angina that keeps coming back (chronic angina).

Walgreens will not offer abortion pills in some states

Walgreens will not offer abortion pills in some states

Walgreens Boots Alliance (WBA) said  Thursday that it will not dispense abortion pills in the states of 20 Republican attorneys general who have told the pharmacy chain it risked breaking the law should it dispense them to the states by mail. The decision comes after the U.S.

Walmart Health plans major expansion

Walmart Health plans major expansion

Walmart plans to add 28 new Walmart Health centers this year, bringing the total number of locations to at least 75 by year-end. The expansion will bring the Walmart Health format into two new states — Missouri and Arizona — while deepening its presence in Texas with additional outlets in the Dallas

WBA sells 15.5 million shares of Option Care Health

WBA sells 15.5 million shares of Option Care Health

Walgreens Boots Alliance (WBA) announced Thursday  that it has sold 13.0 million shares of Option Care Health (OPCH) common stock in an underwritten secondary offering and, subject to completion of the offering, a concurrent share repurchase by OPCH in the amount of approximately 2.5 million shares.

House committee investigation keeps the heat on PBMs, NCPA says

House committee investigation keeps the heat on PBMs, NCPA says

ALEXANDRIA, Va. – The National Community Pharmacists Association is hailing moves today by the U.S. House of Representatives’ Committee on Oversight and Accountability to launch an investigation into pharmacy benefit managers. Kicking off the probe, Chairman James Comer (R-Ky.

Lilly cuts insulin prices by 70%

Lilly cuts insulin prices by 70%

Eli Lilly and Co. announced price reductions of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value Program that caps patient out-of-pocket costs at $35 or less per month.